- Home
- KURA vs NAT Comparison
KURA vs NAT Comparison
Compare KURA & NAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KURA | NAT |
|---|---|---|
| Founded | 2014 | 1995 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2015 | 1997 |
Fundamental Metrics
Financial Performance| Metric | KURA | NAT |
|---|---|---|
| Price | $13.03 | $7.07 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 11 | 2 |
| Target Price | ★ $25.56 | $4.00 |
| AVG Volume (30 Days) | 2.2M | ★ 3.2M |
| Earning Date | 05-12-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 8.50% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $28.28 | $77.72 |
| Revenue Next Year | $106.37 | N/A |
| P/E Ratio | ★ N/A | $525.49 |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $7.36 | $3.06 |
| 52 Week High | $13.90 | $7.20 |
Technical Indicators
Market Signals| Indicator | KURA | NAT |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 61.96 |
| Support Level | $7.96 | $5.42 |
| Resistance Level | $13.90 | $7.20 |
| Average True Range (ATR) | 0.68 | 0.24 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 73.57 | 81.70 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
About NAT Nordic American Tankers Limited
Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.